{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:43:08Z","timestamp":1792118588590,"version":"4.4.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T00:00:00Z","timestamp":1544572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,26]]},"DOI":"10.1093\/ecco-jcc\/jjy206","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T20:10:23Z","timestamp":1544299823000},"page":"578-584","source":"Crossref","is-referenced-by-count":60,"title":["Management of Paediatric Patients With Medically Refractory Crohn\u2019s Disease Using Ustekinumab: A Multi-Centred Cohort Study"],"prefix":"10.1093","volume":"13","author":[{"given":"Mallory","family":"Chavannes","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Sainte-Justine UHC, University of Montreal, QC, Canada"},{"name":"Department of Paediatrics, Children Hospital of Los Angeles, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Martinez-Vinson","sequence":"additional","affiliation":[{"name":"Division of Paediatric Gastroenterology, H\u00f4pital Robert-Debr\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Hart","sequence":"additional","affiliation":[{"name":"Montreal Children\u2019s Hospital, Department of Paediatrics, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kaniki","sequence":"additional","affiliation":[{"name":"Research Western, Western University, London, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Yung","family":"Chao","sequence":"additional","affiliation":[{"name":"Montreal Children\u2019s Hospital, Department of Paediatrics, McGill University, Montreal, QC, Canada"},{"name":"Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Division of Paediatric Gastroenterology Hepatology and Nutrition, BC Children\u2019s Hospital, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevan","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Division of Paediatric Gastroenterology Hepatology and Nutrition, BC Children\u2019s Hospital, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Hugot","sequence":"additional","affiliation":[{"name":"Division of Paediatric Gastroenterology, H\u00f4pital Robert-Debr\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9rome","family":"Viala","sequence":"additional","affiliation":[{"name":"Division of Paediatric Gastroenterology, H\u00f4pital Robert-Debr\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"},{"name":"UFR de M\u00e9decine, Universit\u00e9 Paris Diderot-Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Deslandres","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Sainte-Justine UHC, University of Montreal, QC, Canada"},{"name":"Research Centre of CHU Sainte-Justine, University of Montreal, Montreal, QCc, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prevost","family":"Jantchou","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Sainte-Justine UHC, University of Montreal, QC, Canada"},{"name":"Research Centre of CHU Sainte-Justine, University of Montreal, Montreal, QCc, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest G","family":"Seidman","sequence":"additional","affiliation":[{"name":"Montreal Children\u2019s Hospital, Department of Paediatrics, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"key":"2019042621331457300_CIT0001","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","article-title":"Inflammatory bowel disease in children and adolescents","volume":"169","author":"Rosen","year":"2015","journal-title":"JAMA Pediatr"},{"key":"2019042621331457300_CIT0002","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/gutjnl-2012-302830","article-title":"Mucosal healing in inflammatory bowel diseases: a systematic review","volume":"61","author":"Neurath","year":"2012","journal-title":"Gut"},{"key":"2019042621331457300_CIT0003","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/MIB.0000000000000816","article-title":"Endoscopic mucosal healing predicts favorable clinical outcomes in inflammatory bowel disease: a meta-analysis","volume":"22","author":"Reinink","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2019042621331457300_CIT0004","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1053\/j.gastro.2006.12.003","article-title":"Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn\u2019s disease in children","volume":"132","author":"Hyams","year":"2007","journal-title":"Gastroenterology"},{"key":"2019042621331457300_CIT0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/j.gastro.2012.04.046","article-title":"Safety and efficacy of adalimumab for moderate to severe Crohn\u2019s disease in children","volume":"143","author":"Hyams","year":"2012","journal-title":"Gastroenterology"},{"key":"2019042621331457300_CIT0006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.crohns.2011.07.011","article-title":"Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn\u2019s disease: a large single-centre experience","volume":"6","author":"Sprakes","year":"2012","journal-title":"J Crohns Colitis"},{"key":"2019042621331457300_CIT0007","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"2019042621331457300_CIT0008","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajg.2011.73","article-title":"Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis","volume":"106","author":"Ford","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2019042621331457300_CIT0009","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ajg.2008.88","article-title":"Loss of response and requirement of infliximab dose intensification in Crohn\u2019s disease: a review","volume":"104","author":"Gisbert","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"2019042621331457300_CIT0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2036.2011.04612.x","article-title":"Review article: loss of response to anti-TNF treatments in Crohn\u2019s disease","volume":"33","author":"Ben-Horin","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"2019042621331457300_CIT0011","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1053\/j.gastro.2008.07.014","article-title":"A randomized trial of Ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with moderate-to-severe Crohn\u2019s disease","volume":"135","author":"Sandborn","year":"2008","journal-title":"Gastroenterology"},{"key":"2019042621331457300_CIT0012","first-page":"1519","volume-title":"Ustekinumab Induction and Maintenance Therapy in Refractory Crohn\u2019s Disease.","author":"Sandborn","year":"2012"},{"key":"2019042621331457300_CIT0013","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N Engl J Med"},{"key":"2019042621331457300_CIT0014","doi-asserted-by":"crossref","first-page":"S585","DOI":"10.1016\/S0016-5085(17)32105-4","article-title":"Long-term efficacy and safety of ustekinumab for Crohn\u2019s disease: results from Im-Uniti long-term extension through two years","volume":"152","author":"Sandborn","year":"2017","journal-title":"Gastroenterology"},{"key":"2019042621331457300_CIT0015","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaad.2015.07.002","article-title":"Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study","volume":"73","author":"Landells","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2019042621331457300_CIT0016","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S0016-5085(18)30724-8","article-title":"Ustekinumab responders versus non-responders in refractory pediatric inflammatory bowel disease","volume":"154","author":"Fusillo","year":"2018","journal-title":"Gastroenterology"},{"key":"2019042621331457300_CIT0017","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/MPG.0000000000000503","article-title":"Ustekinumab for resistant pediatric Crohn disease","volume":"62","author":"Rinawi","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019042621331457300_CIT0018","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MPG.0000000000001146","article-title":"Ustekinumab in pediatric Crohn disease patients","volume":"63","author":"Bishop","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019042621331457300_CIT0019","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/MPG.0000000000000608","article-title":"Ustekinumab in treatment of refractory paediatric Crohn disease","volume":"62","author":"Cameron","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2019042621331457300_CIT0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ibd.21649","article-title":"Mathematical weighting of the pediatric Crohn\u2019s disease activity index [PCDAI] and comparison with its other short versions","volume":"18","author":"Turner","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"2019042621331457300_CIT0021","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/gut.27.7.809","article-title":"Differing acute phase responses in Crohn\u2019s disease and ulcerative colitis","volume":"27","author":"Saverymuttu","year":"1986","journal-title":"Gut"},{"key":"2019042621331457300_CIT0022","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cgh.2015.09.018","article-title":"Subcutaneous ustekinumab provides clinical benefit for two-thirds of patients with Crohn\u2019s disease refractory to anti-tumor necrosis factor agents","volume":"14","author":"Wils","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019042621331457300_CIT0023","doi-asserted-by":"crossref","first-page":"S410","DOI":"10.1016\/S0016-5085(17)31602-5","article-title":"Ustekinumab is effective for inducing clinical, endoscopic, and radiographic response and remission in refractory moderate-to-severe Crohn\u2019s disease: a multicentre cohort study","volume":"152","author":"Ma","year":"2017","journal-title":"Gastroenterology"},{"key":"2019042621331457300_CIT0024","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.crohns.2014.06.005","article-title":"Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn\u2019s disease\u2014the McGill experience","volume":"8","author":"Kopylov","year":"2014","journal-title":"J Crohns Colitis"},{"key":"2019042621331457300_CIT0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MIB.0000000000000624","article-title":"Patients with refractory Crohn\u2019s disease successfully treated with ustekinumab","volume":"22","author":"Harris","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2019042621331457300_CIT0026","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/apt.14016","article-title":"Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn\u2019s disease: real world experience from a multicentre cohort","volume":"45","author":"Ma","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2019042621331457300_CIT0027","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/MIB.0000000000001074","article-title":"Long-term maintenance of clinical, endoscopic, and radiographic response to ustekinumab in moderate-to-severe Crohn\u2019s disease: real-world experience from a multicenter cohort study","volume":"23","author":"Ma","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2019042621331457300_CIT0028","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.2147\/DDDT.S102141","article-title":"Ustekinumab in treatment of Crohn\u2019s disease: design, development, and potential place in therapy","volume":"10","author":"Deepak","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"2019042621331457300_CIT0029","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaad.2011.06.011","article-title":"Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis [Part I of II]: results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials","volume":"66","author":"Lebwohl","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2019042621331457300_CIT0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/09546634.2010.534430","article-title":"Flare of pustular psoriasis after initiating ustekinumab therapy","volume":"23","author":"Wenk","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"2019042621331457300_CIT0031","first-page":"202","article-title":"Successful management of ustekinumab-induced pustular psoriasis without therapy discontinuation","volume":"21","author":"Caca-Biljanovska","year":"2013","journal-title":"Acta Dermatovenerol Croat"},{"key":"2019042621331457300_CIT0032","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/ced.12392","article-title":"Paradoxical flare of pustular psoriasis triggered by ustekinumab, which responded to adalimumab therapy","volume":"39","author":"Hay","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"2019042621331457300_CIT0033","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.cgh.2017.03.032","article-title":"Association between ustekinumab trough concentrations and clinical, biomarker, and endoscopic outcomes in patients with Crohn\u2019s disease","volume":"15","author":"Battat","year":"2017","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/13\/5\/578\/28534675\/jjy206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T02:28:16Z","timestamp":1556332096000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/13\/5\/578\/5240165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,12]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,12,12]]},"published-print":{"date-parts":[[2019,4,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy206","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2018,12,12]]}}}